跳至主要内容
临床试验/ITMCTR2200005686
ITMCTR2200005686尚未招募1 期

A prospective, randomized, double-blind, parallel, placebo-controlled, multicenter clinical study of acupoint application in the treatment of endometriosis

Affiliated Hospital of Shandong University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 45(—)
性别
Female

入选标准

  • 1. Meet the diagnostic criteria of endometriosis;
  • 2. Age 18-45, menstrual cycle 21-35 days, period 3-7 days;
  • 3. Patients with mass diameter < 4 cm;
  • 4.35IU/L < serum CA125 < 80IU/L;
  • 5. Informed consent and signing of informed consent.

排除标准

  • 1. Dysmenorrhea caused by various primary dysmenorrhea or other diseases;
  • 2. Have accepted other new drug clinical experimenter in recent 3 months;
  • 3. People with coagulation disorder;
  • 4. People who have been allergic to multiple drugs or have an allergic constitution;
  • 5. Persons with combined mental illness, alcoholism and/or psychoactive substance substance abuse and dependence;
  • 6. Patients with skin trauma, ulcers, skin infection or scar at the application site and those who are allergic to the patch;
  • 7. Pregnant or lactating women.
  • Note: any one or more of the above items should be excluded and cannot be selected.

研究者

发起方
Affiliated Hospital of Shandong University of Traditional Chinese Medicine

相似试验